Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]
Sinkey RG +6 more
europepmc +1 more source
Saroglitazar and vitamin E vs. lifestyle interventions in metabolic dysfunction associated steatotic liver disease: A 3-arm randomised study. [PDF]
Tiwari AK +10 more
europepmc +1 more source
Effect of nanoliposomal gamma-oryzanol on cryosurvival, oxidative balance, and fertility of frozen-thawed ram spermatozoa. [PDF]
Abbasi R +3 more
europepmc +1 more source
Congenital Isolated Unilateral Agenesis of Pulmonary Arteries with 3-Year Follow-Up after Initiation of Treatment. [PDF]
Nakata M +4 more
europepmc +1 more source
Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial. [PDF]
Bhagat N +8 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]
Fraquelli M +5 more
europepmc +1 more source
Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol. [PDF]
He K +21 more
europepmc +1 more source
Quantification of the role of lead foil in flattening filter free beam reference dosimetry. [PDF]
Gao S +7 more
europepmc +1 more source
Corn Oil Oleogel With γ-Oryzanol/β-Sitosterol: Structural, Thermal, Textural, and Oxidative Characterization. [PDF]
Elbir Abca T, Gençcelep H.
europepmc +1 more source
Targeting PI3K/Akt/mTOR Pathway, Ki-67 and Endothelin Receptors by Ambrisentan in Juvenile Rat Intestinal Ischemia. [PDF]
Refaie MMM +13 more
europepmc +1 more source

